Litronesib
Based on 2 publication(s) in Google Scholar
Litronesib (LY2523355) is a selective mitosis-specific kinesin Eg5 inhibitor, with antitumor activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.35%
- CAS. Nr.: 910634-41-2
- Formel: C23H37N5O4S2
- Molecular Weight:511.70
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
Cell Cycle/DNA Damage Compound Library
HY-L004
-
Anti-Cancer Compound Library
HY-L025
-
Clinical Compound Library
HY-L026
-
Anti-Aging Compound Library
HY-L034
-
Drug Repurposing Compound Library
HY-L035
-
Cytoskeleton Compound Library
HY-L060
-
Targeted Diversity Library
HY-L099
-
Anti-Prostate Cancer Compound Library
HY-L124
-
Pain-Related Compound Library
HY-L139
-
Highly Selective Inhibitors Library
HY-L158
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Drug Repurposing Compound Library Plus
HY-L035P
-
Clinical Compound Library Plus
HY-L026P
-
Bioactive Compound Library
HY-L001
-
High-Throughput Bioactive Compound Library
HY-L205
Publications Citing Use of MedChemExpress (MCE) Litronesib
MoreAlle Kinesin Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
Eg5 |
Litronesib (LY2523355) is a selective Eg5 inhibitor. Litronesib (25 nM) induces cancer cells to death during mitotic arrest, and this needs sustained activation of spindle-assembly checkpoint (SAC)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 910634-41-2
-
Appearance Solid
-
Molecular Weight 511.70
-
Formel C23H37N5O4S2
-
Color White to off-white
-
SMILES
CC(C)(C)C(N1[C@@](C2=CC=CC=C2)(CNS(CCNCC)(=O)=O)SC(NC(C(C)(C)C)=O)=N1)=O
-
Synonyms
LY2523355
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Life Sci Alliance
Kinesins regulate the heterogeneity in centrosome clustering after whole-genome duplication. [Abstract]2024 Jul 29;7(10):e202402670. PMID: 39074902 -
Gene
2025 Apr 3:955:149458. PMID: 40187619
Lösungsmittel & Löslichkeit
DMSO : ≥ 50 mg/mL (97.71 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
* "≥" means soluble, but saturation unknown.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.89 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.89 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protokoll
Cancer cells are plated in poly-d-lysine coated 96-well plates and incubated overnight. Cells are then treated with indicated concentrations of Litronesib for various time periods. Cells are then fixed with 3.7% formaldehyde in PBS for 45 minutes or 1× Prefer fixative solution for 30 minutes, at room temperature, and permeabilized with cold methanol for 10 minutes and then 0.2% Triton X-100 in PBS for 10 minutes. Cells are washed three times with PBS. Cells are then incubated with 100 μg/mL DNase-free RNase and 10 μg/mL of propidium iodide for 1 hour and scanned for mitotic index (MI) measurement based on DNA condensation as percentage of cells with condensed DNA. For MI based on histone H3 phosphorylation or apoptosis analysis, cells are incubated overnight at 4°C with anti-phospho-histone H3 antibody or anti-phospho-histone H2AX at 1:1,000 dilution with 5% bovine serum albumin (BSA) in PBS, respectively. Cells are washed three times with 0.2% Triton-X 100 in PBS and incubated with Alexa 488 secondary antibody (1:1,000 in PBS-2% BSA) for 60 minutes at room temperature. Cells are washed three times again with PBS and stained for 15 minutes in PBS containing 10 μg/mL propidium iodide and 100 μg/mL RNaseA. The stained cells are scanned with an Acumen Explorer eX3 microplate cytometer. The results are expressed as percentage of cells positive for phospho-histone H3-Ser10 or phospho-histone H2AX[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Primary human-tumor xenograft models are established and maintained in nude mice. Antitumor efficacy in subcutaneous xenograft tumor-bearing mice with 10 mice per treatment group from either established cancer cell lines or fragments of human tumor explants is evaluated as tumor volume by serial caliper measurements and is calculated. The p388 syngeneic tumor model is developed for high-content imaging analysis using female BDF1 mice, weighing 20 to 23 g, which are acclimated in-house for one week before their use in experiments. p388 murine lymphocytic leukemia cells are authenticated by STR assay and maintained in RPMI1640 medium containing 10% FBS. For inoculation, the cells are washed with serum-free medium three times and 1.25 million cells are implanted by intraperitoneal injection into mice. On day 5 after implantation, mice are treated with Litronesib, via either intravenous bolus or intravenous infusion at appropriate doses and durations. Mice are euthanized and the ascitic (intraperitoneal) fluid containing the p388 tumor cells is drawn and analyzed by acumen, flow cytometry, and TUNEL assays for phospho-histone H3, G2-M, and apoptosis. For pharmacokinetic study, the blood samples are collected via cardiac puncture and generated plasma with EDTA and determined Litronesib exposure in the plasma[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Reinheit & Dokumentation
-
Data Sheet (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9543 mL | 9.7714 mL | 19.5427 mL | 48.8568 mL |
| 5 mM | 0.3909 mL | 1.9543 mL | 3.9085 mL | 9.7714 mL | |
| 10 mM | 0.1954 mL | 0.9771 mL | 1.9543 mL | 4.8857 mL | |
| 15 mM | 0.1303 mL | 0.6514 mL | 1.3028 mL | 3.2571 mL | |
| 20 mM | 0.0977 mL | 0.4886 mL | 0.9771 mL | 2.4428 mL | |
| 25 mM | 0.0782 mL | 0.3909 mL | 0.7817 mL | 1.9543 mL | |
| 30 mM | 0.0651 mL | 0.3257 mL | 0.6514 mL | 1.6286 mL | |
| 40 mM | 0.0489 mL | 0.2443 mL | 0.4886 mL | 1.2214 mL | |
| 50 mM | 0.0391 mL | 0.1954 mL | 0.3909 mL | 0.9771 mL | |
| 60 mM | 0.0326 mL | 0.1629 mL | 0.3257 mL | 0.8143 mL | |
| 80 mM | 0.0244 mL | 0.1221 mL | 0.2443 mL | 0.6107 mL |
Litronesib Related Classifications
HY-14846 Related Classifications
Powered by Bioz